OnKure Therapeutics (OKUR) AGM 2026 summary

Opening remarks and agenda

• Meeting called to order by the Chair, with introductions of directors, officers, and external representatives present.

• Agenda included election of three Class II directors, ratification of the independent auditor, and amendment of the 2024 Equity Incentive Plan.

Board and executive committee updates

• Board nominees for Class II directors were R. Michael Carruthers, Valerie M. Jansen, and Edward T. Mathers.

• Board recommended votes in favor of all proposals presented.

Shareholder proposals

• Proposals included electing three directors, ratifying KPMG as auditor, and amending the equity incentive plan to increase reserved shares by 8% and remove the annual share limit.